• Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex7-9dup; Zygosity=Unspecified (PubMed=14676279).
  

PubMed=8101511; DOI=10.1002/ijc.2910540621
Ferrandis E., Benard J.
Activation of the human MDR1 gene promoter in differentiated neuroblasts.
Int. J. Cancer 54:987-991(1993)

DOI=10.1007/0-306-46872-7_2
Thiele C.J.
Neuroblastoma.
(In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999)

PubMed=10686938; DOI=10.1016/S0165-4608(98)00264-7
Valent A., Benard J., Venuat A.-M., Da Silva J., Duverger A., Duarte N., Hartmann O., Spengler B.A., Bernheim A.
Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.
Cancer Genet. Cytogenet. 112:124-129(1999)

PubMed=11464856; DOI=10.1002/1096-911X(20010101)36:1<100::AID-MPO1023>3.0.CO;2-G
Valent A., Venuat A.-M., Danglot G., Da Silva J., Duarte N., Bernheim A., Benard J.
Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Med. Pediatr. Oncol. 36:100-103(2001)

PubMed=14676279; DOI=10.1242/jcs.00834
Goldschneider D., Blanc E., Raguenez G., Barrois M., Legrand A., Le Roux G., Haddada H., Benard J., Douc-Rasy S.
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
J. Cell Sci. 117:293-301(2004)